Skip to the content

VYNE Therapeutics

Rooted in Innovation

About Us
Pipeline
Careers
Investors & Media
Contact Us

Search for:

About Us
Pipeline
Careers
Investors & Media
Contact Us

VYN202 P1a SAD/MAD Data

Post date December 23, 2024
Post categories In Uncategorized

VYN202-P1a-SADMAD-Data

Post navigation

←Previous post:VYNE Therapeutics Reports Positive Top-line Phase 1a MAD Data for VYN202, its Novel BD2-Selective BET Inhibitor

About Us

About VYNE^®
Our Mission
Who We Are
Leadership
Board of Directors
Corporate Responsibility
Contact Us

Pipeline

Pipeline Overview
InhiBET™ BET Inhibitor Platform
VYN201
VYN202

Investors

Investor Overview
Stock Information
Press Releases
Events & Presentations
Investors & Media
In the News
ES&G / Culture
Corporate Governance
Filings & Financials

Careers

Job Openings
Our Mission

Terms of Use
Privacy Policy
Social Media Guidelines
Compliance
Site Map

© 2024 Vyne Therapeutics Inc. All Rights Reserved

You Are Leaving VYNETherapeutics.com

Return to
VYNE Therapeutics

Continue to
Amzeeq.com

You Are Leaving VYNETherapeutics.com

Return to
VYNE Therapeutics

Continue to
Zilxi.com